Marburg | Global Biodefense

Menu

Marburg Infection Protective Antibody Response Mechanism Uncovered

Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform

by Global Biodefense Staff March 3, 2020, 6:04 pm
Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

by Global Biodefense Staff February 10, 2020, 6:48 pm
Inhibiting PP2A-B56 to Suppress Ebola Virus Transcription and Infection

by Global Biodefense Staff January 22, 2018, 8:56 pm
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures

by Global Biodefense Staff November 16, 2017, 12:49 pm
NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses

by Global Biodefense Staff October 10, 2017, 3:24 pm
Monoclonal Antibody Cures Late-Stage Marburg Infection in Monkeys

by Global Biodefense Staff April 6, 2017, 6:26 am
PHEMCE Review: Accomplishments and Future Areas of Opportunity

by Rebecca Fish March 2, 2017, 8:37 am
GAO Recommendations on Select Agent Program Improvements

by Global Biodefense Staff September 26, 2016, 1:33 am
Advanced Development of Filovirus and Lassa Fever Vaccines

by Global Biodefense Staff March 13, 2016, 4:01 pm
A Lengthy Arms Race Between Ebola and Bats

by Global Biodefense Staff December 23, 2015, 11:39 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
USAMRIID Seeks Mouse Supply for Filovirus Research

by Global Biodefense Staff December 22, 2015, 11:35 am
DoD CBRN Medical Countermeasure Consortium

by Global Biodefense Staff November 16, 2015, 12:53 pm
Handicapping Ebola to Buy Immune System Time to Respond

by Global Biodefense Staff November 2, 2015, 9:24 am
RFI – Vaccine Candidates and Technologies for Filoviruses

by Global Biodefense Staff August 18, 2015, 10:28 am

Congratulations. You've reached the end of the internet.

Back to Top

Close